Spinal Fusion Surgery Rebuked In NEJM “Sounding Board” Article
This article was originally published in The Gray Sheet
Executive Summary
FDA should provide closer scrutiny of spinal implants and their use for unapproved indications, according to scientists critical of emerging technologies for spinal fusion surgery